small sized icon representing the Cardiovascular area of interest
Cardiorenal
small sized icon representing the Hematology area of interest
Hematología
small sized icon representing the Ophthalmology area of interest
Oftalmología
small sized icon representing the Oncology area of interest
Oncología
small sized icon representing the Women's Health area of interest
Salud de la Mujer
SPACETu portal médico
Cardiovascular

Anticoagulation in high risk patients with atrial fibrillation – Episode 1

29:16 minutos

 

In this episode, Dr Yassir Javaid gives us his advice on getting to know your patients with atrial fibrillation and diabetes , Professor Craig Coleman explains the results of the CALLIPER study and Dr Manesh Patel and Dr Christian Ruff look at the issues surrounding stroke prevention in an older patient with renal impairment and tell us how COVID-19 is affecting the treatment of patients with cardiovascular disease.

 

Further Details

• For more information on the number of strokes that can be prevented click here eiuperspectives.economist.com/health­care…n-progress
• Details on the number of patients of atrial fibrillation and comorbid diabetes can be found on our page on Thrombosis Adviser www.thrombosisadviser.com/diabetes
• Data showing how diabetes doubles the rate of renal decline over 2 years are available in this publication pubmed.ncbi.nlm.nih.gov/27­073197/
• Full results of the CALLIPER study are presented here academic.oup.com/eurheartj/articl…tedFrom=fulltext
• The 2019 American Heart Association/American College of Cardiology/Heart Rhythm Society Focused Update of the Guideline for the Management of Patients With Atrial Fibrillation is available here
• The European Society of Cardiology Guidelines for the Management of Atrial Fibrillation can be read here pubmed.ncbi.nlm.nih.gov/16531986/
• For anticoagulant dosing information see the European labels for apixaban (www.ema.europa.eu/en/documents/pro…formation_en.pdf
), dabigatran (www.ema.europa.eu/en/documents/pro…formation_en.pdf), edoxaban (www.ema.europa.eu/en/documents/pro…formation_en.pdf), rivaroxaban (www.ema.europa.eu/en/documents/pro…formation_en.pdf) and warfarin (www.medicines.org.uk/emc/product/3064/­smpc)

Recording approval code: PP-XAR-ALL-1800-1;
Shownotes approval code: PP-M_RIV-ALL-0113-1

 

Última actualización: 28.10.2022